相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Matrix Metalloproteinases 2, 7, and 9 and Tissue Inhibitor of Metalloproteinases-1 in Tumors and Serum of Patients with Ovarian Neoplasms
E. S. Gershtein et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
MMP-7 overexpression is an independent prognostic marker in gastric cancer
Selja Koskensalo et al.
TUMOR BIOLOGY (2010)
The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis
William Cruz-Munoz et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2008)
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer
Zheng-Sheng Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
N. G. Hurst et al.
BRITISH JOURNAL OF CANCER (2007)
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer
S. Sillanpaa et al.
GYNECOLOGIC ONCOLOGY (2007)
Matrix metalloproteinase-induced malignancy in mammary epithelial cells
Melody Stallings-Mann et al.
CELLS TISSUES ORGANS (2007)
Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer
S. Sillanpaa et al.
TUMOR BIOLOGY (2007)
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to β-catenin expression
Sari M. Sillanpaa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Circulating MMP2 and MMP9 in breast cancer - Potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories
Stella B. Somiari et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions
O. Graesslin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Matrix metalloproteinases-2 and-9 in cervical cancer:: different roles in tumor progression
M. Rauvala et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer
AA Kamat et al.
CLINICAL CANCER RESEARCH (2006)
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase
FQ Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma
L Manenti et al.
EUROPEAN JOURNAL OF CANCER (2003)
Matrix metalloproteinases in cancer:: Prognostic markers and therapeutic targets
P Vihinen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer
E Lengyel et al.
GYNECOLOGIC ONCOLOGY (2001)
分享论文
